Forward Pharmaceuticals

Forward Pharmaceuticals, based in Shenzhen, China, is a biotechnology company. Forward Pharma is a clinical-stage biotechnology company focused exclusively on oncology drug development, using structural characterisation, biophysical profiling and computational optimisation. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing FWD1802 in HR-positive / HER2-negative breast cancer. The largest, NCT07002177 (A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC), plans to enrol 196 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.